Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tacholiquine,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase IV
Sponsor : Medaimun GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 05, 2015
Lead Product(s) : Tacholiquine,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase IV
Sponsor : Medaimun GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable